Introduction
Epilepsy is a major neurological disorder and up to 5% of the world population develops epilepsy in their lifetime 1 . The current therapy of epilepsy with modern antiepileptic drugs is associated with side effects, dose-related and chronic toxicity, as well as teratogenic effects, and approximately 30% of the patients continue to have seizures with current antiepileptic drugs therapy [2] [3] [4] . Traditional systems of medicine are popular in developing countries and up to 80% of the population relies on traditional medicines or folk remedies for their primary health care need 5 . Medicinal plants are believed to be an important source of new chemical substances with potential therapeutic effects 6 . Several plants used for the treatment of epilepsy in different systems of traditional medicine have shown activity when tested in modern bioassays for the detection of anticonvulsant activity 7 and many such plants are yet to be scientifically investigated.
Carissa carandas Linn. (Syn. Carissa congesta Wight) is a large dichotomously branched evergreen shrub with short stem and strong thorns in pairs, belonging to family Apocynaceae. The plant is native and common throughout much of India, Sri Lanka, Java, Malaysia, Myanmar and Pakistan. In traditional system of medicine, the plant is used as an anthelmintic, astringent, appetizer, antipyretic, in biliary, stomach disorders, rheumatism and disease of the brain 8 . Earlier studies have shown that the extract of the plant possesses cardiotonic, antipyretic and antiviral activity [9] [10] [11] . Various cardiac glycosides, a triterpenoidal constituent carissone and β-sitosterol were reported from the root extract of the plant 9, 12 . In Western Ghats region of India, the decoctions and extracts of the roots of this plant are effective remedies in the management and/or control of convulsions and epilepsy. However, no scientific data are available to validate the folklore claim. The aim of the present study was, therefore, to evaluate the anticonvulsant potential of the ethanol extract of the roots of C. carandas in experimental animal models, with a view to providing a pharmacological justification (or otherwise) for the ethnomedical use of the plant's root in the management of convulsions and epilepsy in some rural communities of India.
Materials and Methods

Plant material
The roots of C. carandas were collected from Udupi, Karnataka, during April 2006. It was authenticated by Dr. Gopalakrishna Bhat, Department of Botany, Poorna Prajna College, Udupi, Karnataka, India. A voucher specimen (no. 105a) is deposited in the herbarium of our institute.
Preparation of extract
Fresh roots were collected and dried in the shade. The shade-dried roots of the plant (500 gm) were powdered and soaked in 1.5 L of 95% ethyl alcohol for 4 days and the liquid extract was decanted. The process of soaking and decanting was repeated for 4 times with fresh solvent. The solvent of the total liquid extract was evaporated by distillation to a concentrate over a water bath to a syrupy consistency and then evaporated to dryness under vacuum to give the dry extract (16% w/w yield). The extract was stored at 4 °C until used as a suspension with 2% Tween 80/saline.
Experimental animals
Swiss mice of either sex, 8-10 weeks old, weighing about 25-30 g were used in experiments. Animals were housed in polypropylene cages maintained under standard condition (12 hours light / dark cycle; 25 ± 3 0 C, 45-65% humidity) and had free access to standard rat feed (Hindustan Liver Ltd., India) and water ad libitum. All the animals were acclimatized to laboratory condition for a week before commencement of experiment. All experimental protocols were reviewed and accepted by the Institutional Animal Ethical Committee (IAEC) prior to the initiation of the experiment.
Drugs and chemicals
Pentylenetetrazole (PTZ; Sigma Chemical Co.), picrotoxin (PC; Sigma Chemical Co.), Nmethyl-dl-aspartic acid (NMDLA; Sigma Chemical Co.), phenobarbitone (PHNB; Phenetone, Cipla, India) and 5,5-diphenylhydantoin sodium salt (Phenytoin, PHNY; Sigma Chemical Co.) were all dissolved in physiological saline. +Bicuculline (BC; Sigma Chemical Co.) was suspended in 0.5 ml of Tween 80 (Ranbaxy Laboratories Ltd) and adjusted to an appropriate volume with physiological saline. Diazepam (DZP; Calmpose, Ranbaxy Pharma, India) was also suspended in a minimum amount of polyethylene glycol 400 (Ranbaxy Laboratories Ltd) and adjusted to an appropriate volume with physiological saline. Fresh drug solutions were prepared on each day of the experiments. Drugs were administered intraperitoneally (i.p.) in a volume of 1 ml/100 g of animal. Control animals received equal volume of injections of the appropriate vehicle. The doses and pretreatment times of the extract of the roots of C. carandas and the standard antiepileptic drugs used were obtained from preliminary studies in our laboratory. The pretreatment dose and the times following the administration of either pentylenetetrazole (90 mg/kg, i.p.), picrotoxin (10 mg/kg, i.p.), bicuculline (40 mg/kg, i.p.) or NMDLA (400 mg/kg, i.p.) were C. carandas extract (100, 200 and 400 mg/kg, i.p., 30 min), diazepam (0.5 mg/kg, i.p., 20 min), phenobarbitone (10 mg/kg, i.p., 10 min) and phenytoin (25 mg/kg, i.p., 20 min).
Phytochemical screening
The freshly prepared extract of the roots of C. carandas (ERCC) was subjected to phytochemical screening tests for the detection of various constituents 13 .
Acute toxicity study
The toxicity study was determined in mice by modified method of Lorke 14 . Mice fasted for 16 h were randomly divided into groups of 10 mice per group and were administered i.p. with the extract in doses ranging from 100-2000 mg/kg. The procedure described in detail earlier by Ojewole was followed for the determination of the acute toxicity of the plant extract 15 .
Anticonvulsant activity
Electrically-induced seizures
In the electrically-induced seizure experiment, the maximal electroshock (MES) method described previously by Swinyard was employed 16 . In brief, tonic convulsions of the hind extremities of the mice were induced by passing alternating electrical current of 50 Hz and 150 mA for 0.2 sec through corneal electrodes. The animals were divided randomly into 7 groups containing 8 animals each. Group I served as vehicle control group treated with Tween-80 (0.25 ml, i.p., 30 min); groups II, III and IV served as test groups treated with the extract (100, 200 and 400 mg/kg, i.p., 30 min), respectively, and groups V, VI and VII served as reference groups treated with diazepam (0.5 mg/kg, i.p., 20min), phenobarbitone (10 mg/kg, i.p., 10 min) and phenytoin (25 mg/kg, i.p., 20 min), respectively, prior to the induction of convulsion. The number of animals protected from hind limb tonic extension seizure (HLTE) and the time spent in this position were determined for each dose group.
Chemically-induced seizures
The modified method of Vellucci and Webster 17 was used to assess the anticonvulsant effect of the extract. The animals were divided randomly into 7 groups containing 8 animals each and they were treated as described for electrically-induced seizure tests. Seizures were induced in mice with standard convulsing agents, pentylenetetrazole (PTZ), picrotoxin (PC), bicuculline (BC) or N-methyl-dl-aspartic acid (NMDLA) and the animals were observed for 30 min for tonic convulsion episode. Hind limb extension was taken as tonic convulsion. The onset of tonic convulsion and the number of animals convulsing or not convulsing within the observation period were noted. The ability of the plant extract to prevent or delay the onset of the hind limb extension exhibited by the animals was taken as an indication of anticonvulsant activity 18 .
Statistical analysis
The results of the duration of seizures in electrically-induced seizures and onset of seizures in chemically-induced seizures were analyzed using the paired Student's t-test, while the proportion of animals that exhibited tonic seizures in both cases was analyzed using Chi-squared test. A p value of <0.05 was considered as statistically significant.
Results
Phytochemical screening
Phytochemical screening of the extract (ERCC) showed that the crude extract contained small quantities of alkaloids, flavonoids, saponins and large amounts of cardiac glycosides, triterpenoids, phenolic compounds and tannins.
Acute toxicity study
There was no mortality amongst the graded dose groups of mice up to a dose of 2000 mg/kg for duration of 72 h. This finding probably suggests that the ethanol extract is relatively safe or non-toxic in mice at the doses used for this study.
Anticonvulsant assessment
Maximal electroshock produced hind limb tonic extension seizures (HLTE) in all the animals used. The vehicle-treated mice showed tonic hind limb extension for a duration of 15.15 ± 0.19 sec. ERCC (100 mg/kg) significantly reduced the latency, but did not alter the incidence of seizures elicited by maximal electroshock to any significant extent. ERCC at doses of 200 and 400 mg/kg, respectively, protected 25% and 50% of mice and significantly reduced the duration of the seizures. The standard antiepileptic drug, diazepam protected 50% of mice against seizures and significantly reduced the duration of the seizures, while phenobarbitone significantly protected 87.5 % of mice and reduced the duration of the seizures. However, phenytoin completely inhibited the MES-induced tonic seizures in all the animals used (Table 1) .
Pentylenetetrazole produced tonic seizures in all the animals used. A dose of 100 mg/kg of ERCC protected 25% of animals against seizures and did not affect the onset of seizures to any significant extent. ERCC, in doses of 200 and 400 mg/kg, respectively, protected 50% and 62.5% of mice against seizures, and significantly delayed the latency of the seizures. The standard antiepileptic drugs, diazepam and phenobarbitone, completely protected the animals from seizures. Phenytoin neither affected the onset nor the incidence of convulsion to any significant extent, as shown in Table 2 .
Picrotoxin produced tonic seizures in all the animals. ERCC (200 and 400 mg/kg) did not affect the incidence of seizures, but significantly prolonged latency of seizures. The standard antiepileptic drugs, diazepam significantly protected the animals from convulsions and prolonged the latency of seizures, while phenobarbitone did not alter the incidence, but significantly delayed the onset of seizures. Phenytoin neither affected the onset nor the incidence of convulsion to any significant extent (Table 3) .
Bicuculline induced tonic seizures in all the mice used. However, all the doses of ERCC (100, 200 and 400 mg/kg) did not alter the incidence of seizures significantly. Besides, 400 mg/kg of ERCC significantly shortened the latency of seizures in mice. The standard antiepileptic drugs, diazepam and phenobarbitone, completely protected the animals from seizures. Phenytoin neither affected the onset nor the incidence of convulsion to any significant extent (Table 4) .
NMDLA induced tonic seizures in all the mice used. ERCC (200 and 400 mg/kg) significantly prolonged the latency of the seizures. However, only the higher dose (400 mg/kg) protected 25% of the animals from convulsions. The standard antiepileptic drugs, diazepam, phenobarbitone and phenytoin did not significantly affect the incidence or the onset of seizures (see Table 5 ).
Discussion
The results of the present study indicate that ethanol extract of the roots of C. carandas (ERCC) possesses anticonvulsant activity in mice. GABA is the major inhibitory neurotransmitter in the brain while glutamic acid is an excitatory neurotransmitter in the brain. The inhibition of GABA neurotransmitter and the enhancement of the action of glutamic acid have been shown to be the underlying factors in epilepsy 19, 20 . Our study shows that the ethanol extract of the roots of C. carandas protected some of the animals against seizures induced by maximal electroshock, pentylenetetrazole, picrotoxin and NMDLA and also delayed the latency of the seizures.
In the present study maximal electroshock produced seizures in all the animals used. Antiepileptic drugs that block MES-induced tonic extension are known to act by blocking seizure spread 21 . Moreover, drugs that inhibit voltage-dependent Na+ channels, such as phenytoin can prevent MES-induced tonic extension 21, 22 . However, phenobarbitone is as effective against electrically-induced convulsion as it is against pentylenetetrazoleinduced convulsions in mice and phenobarbitone is known to reduce the electrical activity of neurons within a chemically-induced epileptic focus in the cortex, while diazepam does not suppress the focal activity but prevents it from spreading 23, 24 . Diazepam had anticonvulsant effect on both PTZ-induced seizures and maximal electroshock-induced seizures, in which diazepam effect on the former (100% protection) is better than the latter (50% protection). This is consistent with the report that benzodiazepine (BDZ) agonists such as diazepam, clonazepam, etc, are more potent in the prevention of PTZ-induced seizures than in that of MES-induced tonic seizures 25 .
Pentylenetetrazole induced seizures in all the mice used. Pentylenetetrazole may elicit seizures by inhibiting gabaergic mechanisms 26 . Standard antiepileptic drugs, diazepam and phenobarbitone, are believed to produce their effects by enhancing GABAmediated inhibition in the brain 20 . It is, therefore, possible that the anticonvulsant effects shown in this study by the drugs against seizures produced by PTZ might be due to the activation of GABA neurotransmission. Since the extract similarly antagonized seizures elicited by pentylenetetrazole in mice, it is probable, therefore, that it may also be exerting its anticonvulsant effects by affecting gabaergic mechanisms.
Picrotoxin also produced seizures in all the mice used. Picrotoxin is known to elicit seizures, by antagonizing the effect of GABA via blocking of the chloride channels linked to GABA A -receptor 19, 20 . In this study, diazepam and phenobarbitone were shown to antagonize the effect of picrotoxin while the extract was also shown to delay the latency of picrotoxin-induced seizures, suggesting that the extract may be affecting gabaergic mechanisms, probably by opening the chloride channels associated with GABAreceptors.
Bicuculline is a selective antagonist of GABA at the GABA A -receptors 20 . The fact that the extract did not affect the seizures induced by bicuculline, suggests that its effect on gabaergic mechanisms may not be via the stimulation of GABA A -receptors. NMDLA was also shown to elicit seizures in all the mice used. NMDLA, a specific agonist at the NMDA receptors, mimics the action of glutamic acid and thus induces seizures by enhancing the glutaminergic system 20 . It is not surprising that the standard drugs, diazepam and phenobarbitone, did not alter NMDLA-induced seizures to any significant extent. In this study, the extract was shown to delay the latency of seizures induced by NMDLA. It may, therefore, be exerting its anticonvulsant effect partly by affecting glutaminergic mechanisms.
The phytochemical screening of the extract revealed the presence of small quantities of alkaloids, flavonoids, saponins and large amounts of cardiac glycosides, triterpenoids, phenolic compounds and tannins. Based on the present state of knowledge of the chemical constituents of the extract, it is not possible to attribute with certainty its anticonvulsant effect to one or several active principles among those detected in the screening. However, triterpenic steroids and triterpenoidal saponins are reported to possess anticonvulsant activity in some experimental seizure models such as MES and PTZ 27, 28 . Some alkaloids, monoterpenes, flavonoids also have protective effects against PTZ, picrotoxin and NMDLA-induced convulsions [29] [30] [31] [32] . It is worthwhile to isolate the bioactive principles, which are responsible for these activities; the process has commenced in our laboratory. These findings justify the traditional use of this plant in the control and/or treatment of convulsions and epilepsy.
Conclusion
It can be concluded from the study that the anticonvulsant effects of the ethanolic root extract of C. carandas may be via non-specific mechanisms. However, extensive studies are needed to evaluate the precise mechanism(s), active principles, and the safety profile of the plant as a medicinal remedy for convulsive disorders.
